Primary Site >> Colorectal Cancer
Gene >> FLT1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. PMID: 8402650 |
Ref: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. PMID: 7535799 Ref: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. PMID: 7664263 |
Ref: Regulation of vascular endothelial growth factor receptor KDR in vitro by a soluble factor in confluent endothelial cells. PMID: 9732240 |
Ref: Increased expression of angiogenic factors in human colonic angiodysplasia. PMID: 10201485 Ref: A novel gene delivery system targeting cells expressing VEGF receptors. PMID: 10321685 |
Ref: Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. PMID: 10738243 Ref: Angiogenesis of liver metastases: role of sinusoidal endothelial cells. PMID: 10910247 |
Ref: Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. PMID: 11973650 Ref: Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients. PMID: 12168886 |
Ref: Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. PMID: 12739071 Ref: The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. PMID: 12754739 Ref: Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids. PMID: 14521839 Ref: CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. PMID: 14522925 Ref: In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography. PMID: 14570730 |
Ref: Changes in serum soluble VEGFR-1 and Tie-2 receptors in colorectal cancer patients following surgical resections. PMID: 15330184 Ref: Concentrations of VEGF and VEGFR1 in paired tumor arteries and veins in patients with rectal cancer. PMID: 15667002 Ref: (125)I-Vascular endothelial growth factor-121 PMID: 20641207 Ref: (111)In-Diethylenetriamine pentaacetic acid-bevacizumab PMID: 20641545 Ref: Alexa Fluor 680-Bevacizumab PMID: 20641728 Ref: (64)Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-quantum dot-vascular endothelial growth factor PMID: 20641777 Ref: (89)Zr-N-Succinyldesferrioxamine-bevacizumab PMID: 20641842 Ref: (86)Y-CHX-A''-Diethylenetriamine pentaacetic acid-bevacizumab PMID: 21433411 Ref: Anti-vascular endothelial growth factor polylactic acid-polyethylene glycol-poly-L-Lys/gadolinium-diethylenetriamine pentaacetic acid nanoparticles PMID: 22812022 Ref: (64)Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-bevacizumab-IRDye 800CW PMID: 23534080 |
Ref: Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) -- and vascular endothelial growth factor-mediated cellular invasion and tumor growth. PMID: 15665295 Ref: Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. PMID: 15735759 Ref: Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1. PMID: 15771958 Ref: The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. PMID: 15846061 Ref: Silibinin inhibits angiogenesis via Flt-1, but not KDR, receptor up-regulation. PMID: 15993897 Ref: Gene transfer of the vascular endothelial growth factor receptor flt-1 suppresses pulmonary metastasis associated with lung growth. PMID: 16151052 |
Ref: Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. PMID: 16177881 Ref: Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. PMID: 16685275 Ref: In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography. PMID: 16885362 Ref: Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts. PMID: 16928828 Ref: Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. PMID: 17096728 Ref: Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model. PMID: 17127168 Ref: Bone marrow cells in the 'pre-metastatic niche': within bone and beyond. PMID: 17186383 Ref: [The relationship between plasma level of VEGF or soluble Flt-1 and efficacy of hepatic arterial chemotherapy in patients with liver metastasis of colorectal cancer]. PMID: 17212123 |
Ref: Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells. PMID: 17409437 Ref: Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery. PMID: 17512160 Ref: Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients. PMID: 18086000 |
Ref: Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells. PMID: 18172321 Ref: Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. PMID: 18182619 Ref: Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasis. PMID: 18239970 Ref: Hepatic ischemia-reperfusion increases vascular endothelial growth factor and cancer growth in rats. PMID: 18468635 Ref: [Role of vascular endothelial growth factor receptor 1-positive hematopoietic progenitor cell clusters in human colorectal carcinoma metastasis]. PMID: 18504182 Ref: Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas. PMID: 18619649 Ref: Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells. PMID: 18790786 Ref: Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901. PMID: 18790789 |
Ref: Comparative study of human colonic tumor-derived endothelial cells (HCTEC) and normal colonic microvascular endothelial cells (HCMEC): Hypoxia-induced sVEGFR-1 and sVEGFR-2 levels. PMID: 19287991 Ref: Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. PMID: 19582879 Ref: The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation. PMID: 19633424 Ref: Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy. PMID: 19754219 Ref: Using dual-tracer PET to predict the biologic behavior of human colorectal cancer. PMID: 19837754 Ref: Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression. PMID: 19887544 Ref: Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant {beta}-Catenin Activation in Colon Cancer. PMID: 20008853 Ref: Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling. PMID: 20027224 Ref: The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation. PMID: 28001118 |
Ref: Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery. PMID: 19551437 Ref: K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancer. PMID: 19936766 Ref: Blocking effects of siRNA on VEGF expression in human colorectal cancer cells. PMID: 20205278 Ref: Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer. PMID: 20222950 Ref: Tivozanib, a pan-VEGFR tyrosine kinase inhibitor for the potential treatment of solid tumors. PMID: 20799147 Ref: Biological variations in plasma VEGF and VEGFR-1 may compromise their biomarker value in colorectal cancer. PMID: 20873967 Ref: Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment. PMID: 20978198 Ref: [Tracers in oncology - preclinical and clinical evaluation]. PMID: 21152689 Ref: Association of plasma VEGF-A, soluble VEGFR-1 and VEGFR-2 levels and clinical response and survival in advanced colorectal cancer patients receiving bevacizumab with modified FOLFOX6. PMID: 22966290 |
Ref: Prostaglandin E(2) regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cells. PMID: 21070749 Ref: GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway. PMID: 21156786 Ref: sFLT01: a novel fusion protein with antiangiogenic activity. PMID: 21252283 Ref: 18F-FLT-PET for detection of rectal cancer. PMID: 21295872 Ref: Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration. PMID: 21407219 Ref: Co-localization of prothrombin fragment F1+2 and VEGF-R2-bound VEGF in human colon cancer. PMID: 21498704 Ref: Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer. PMID: 21558395 Ref: Early detection of tumor response by FLT/microPET Imaging in a C26 murine colon carcinoma solid tumor animal model. PMID: 21869861 Ref: EGFR- and VEGF(R)-targeted small molecules show synergistic activity in colorectal cancer models refractory to combinations of monoclonal antibodies. PMID: 21880790 Ref: Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells. PMID: 21919647 Ref: Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. PMID: 22174910 |
Ref: The relationship among acute-phase responce proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic. PMID: 21803781 Ref: Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth. PMID: 22065082 Ref: Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft model. PMID: 22167582 Ref: Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment. PMID: 22173549 Ref: Soluble vascular endothelial growth factor decoy receptor FP3 exerts potent antiangiogenic effects. PMID: 22273580 Ref: A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors. PMID: 22421192 Ref: Oxygen breathing affects 3'-deoxy-3'-18F-fluorothymidine uptake in mouse models of arthritis and cancer. PMID: 22492733 Ref: Antitumor effect of FP3 in combination with cetuximab on patient-derived tumor tissue xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases. PMID: 22505231 Ref: 18F-FLT and 125I-IdUrd uptake increase in human tumour cell lines induced by the thymidylate synthase inhibitor FdUrd. PMID: 22576273 Ref: Regorafenib for cancer. PMID: 22577890 Ref: Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases. PMID: 22617773 Ref: New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts. PMID: 22739362 Ref: Significant clinical response of advanced colon cancer to peptide vaccine therapy: a case report. PMID: 22763829 Ref: D-limonene rich volatile oil from blood oranges inhibits angiogenesis, metastasis and cell death in human colon cancer cells. PMID: 22935404 Ref: Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells. PMID: 22992293 Ref: A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylation. PMID: 23059825 Ref: Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors. PMID: 23110215 Ref: [18F]FLT PET for non-invasive assessment of tumor sensitivity to chemotherapy: studies with experimental chemotherapy TP202377 in human cancer xenografts in mice. PMID: 23226334 |
Ref: Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib). PMID: 22664478 Ref: MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. PMID: 22735571 Ref: Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft--no benefit of combination therapy. PMID: 22983756 Ref: VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer. PMID: 23108136 Ref: Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer. PMID: 23314271 Ref: Metformin--an adjunct antineoplastic therapy--divergently modulates tumor metabolism and proliferation, interfering with early response prediction by 18F-FDG PET imaging. PMID: 23376854 Ref: VEGF-B expression in colorectal carcinomas and its relevance for tumor progression. PMID: 23417498 Ref: Critical appraisal of the use of regorafenib in the management of colorectal cancer. PMID: 23610528 Ref: Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells. PMID: 23651517 Ref: Impact of anesthetics on 3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) uptake in animal models of cancer and inflammation. PMID: 23759369 Ref: Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway. PMID: 23799978 Ref: Response to the letter to the editor regarding the manuscript entitled "positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study". PMID: 23813333 Ref: The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells. PMID: 24030632 Ref: Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors. PMID: 24324963 Ref: The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice. PMID: 24339963 Ref: [Treatment outcome of peptide vaccination for advanced colorectal cancer]. PMID: 24393856 Ref: Antitumor effect of FP3 on a patient-derived tumor tissue xenograft model of rectal carcinoma. PMID: 24719933 |
Ref: VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival. PMID: 23794399 Ref: GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction. PMID: 24165321 Ref: Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer. PMID: 24573421 Ref: A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. PMID: 24612787 Ref: Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. PMID: 24621249 Ref: Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings. PMID: 24625025 Ref: Targeting angiogenic pathway for chemoprevention of experimental colon cancer using C-phycocyanin as cyclooxygenase-2 inhibitor. PMID: 24861078 Ref: Prognostic significance of VEGFR1/Flt-1 immunoexpression in colorectal carcinoma. PMID: 24908415 Ref: Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept. PMID: 25136356 Ref: Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer. PMID: 25139485 Ref: [Clinical trial of a seven-peptide vaccine and tegafur-uracil/leucovorin as combination therapy for advanced colorectal cancer]. PMID: 25335716 |
Ref: Soluble VEGFR1 concentration in the serum of patients with colorectal cancer. PMID: 24676933 Ref: Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer. PMID: 25503812 Ref: 3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity. PMID: 25758415 Ref: Positron emission tomography imaging of human colon cancer xenografts in mice with [18F]fluorothymidine after TAS-102 treatment. PMID: 25776904 Ref: Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models. PMID: 25868854 Ref: Efficient inhibition of growth of metastatic cancer cells after resection of primary colorectal cancer by soluble Flt-1. PMID: 25895458 Ref: [(18)F]-FLT PET to predict early response to neoadjuvant therapy in KRAS wild-type rectal cancer: a pilot study. PMID: 25899481 Ref: The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab. PMID: 25926745 Ref: VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells. PMID: 26041938 Ref: A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival. PMID: 26072521 Ref: Expression and clinical significance of vascular endothelial growth factor and fms-related tyrosine kinase 1 in colorectal cancer. PMID: 26137082 Ref: Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival. PMID: 26394830 Ref: Is there a correlation between peripheral blood expression of angiogenic transcriptional factors/receptors and colorectal cancer? PMID: 26537064 |
Ref: LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET. PMID: 25647613 Ref: Involvement of Notch-1 in Resistance to Regorafenib in Colon Cancer Cells. PMID: 26419617 Ref: Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen. PMID: 26974145 Ref: Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells. PMID: 26988990 Ref: Fibrous Dysplasia Presenting as a Cold Spot in 18F-FLT PET/CT Imaging. PMID: 27055128 Ref: Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients. PMID: 27117754 Ref: Genes, environment and gene expression in colon tissue: a pathway approach to determining functionality. PMID: 27186328 Ref: Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma. PMID: 27272777 Ref: BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer. PMID: 27401244 Ref: DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling. PMID: 27517319 Ref: Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts. PMID: 27543111 |
Ref: Colorectal polypoid lesions and expression of vascular endothelial growth factor in a consecutive series of endoscopic and surgical patients. PMID: 28347226 Ref: VEGF, Flt-1, and microvessel density in primary tumors as predictive factors of colorectal cancer prognosis. PMID: 28357103 Ref: Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1alpha and VEGF receptors. PMID: 28594907 Ref: Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion. PMID: 28742793 Ref: A pilot study for texture analysis of (18)F-FDG and (18)F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery. PMID: 28770274 Ref: [(18)F]fluorothymidine PET Informs the Synergistic Efficacy of Capecitabine and Trifluridine/Tipiracil in Colon Cancer. PMID: 29055019 Ref: Vascular endothelial growth receptor 1 acts as a stress-associated protein in the therapeutic response to thalidomide. PMID: 29075340 Ref: Flt-1-positive cells are cancer-stem like cells in colorectal carcinoma. PMID: 29100318 |
Ref: Assessing tumor angiogenesis in colorectal cancer by quantitative contrast-enhanced endoscopic ultrasound and molecular and immunohistochemical analysis. PMID: 28685747 Ref: Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer. PMID: 29282362 Ref: IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides. PMID: 29498403 Ref: Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using (18)F-FDG and (18)F-FLT. PMID: 29571649 Ref: Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. PMID: 29636300 Ref: Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy. PMID: 29721065 Ref: Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers. PMID: 30032643 Ref: Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy. PMID: 30217739 Ref: Irinotecan-Eluting 75-150-mum Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study. PMID: 30337148 |